Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial

INTRODUCTION: Remifentanil is an opioid with a unique pharmacokinetic profile. Its organ-independent elimination and short context-sensitive half time of 3 to 4 minutes lead to a highly predictable offset of action. We tested the hypothesis that with an analgesia-based sedation regimen with remifent...

Descripción completa

Detalles Bibliográficos
Autores principales: Muellejans, Bernd, Matthey, Thomas, Scholpp, Joachim, Schill, Markus
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550941/
https://www.ncbi.nlm.nih.gov/pubmed/16780597
http://dx.doi.org/10.1186/cc4939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550941/
https://www.ncbi.nlm.nih.gov/pubmed/16780597
http://dx.doi.org/10.1186/cc4939

Ejemplares similares